CoQ-10 300MG by Ortho Molecular Products
Ortho Molecular Products' CoQ-10 300 MG is a highly concentrated cardiovascular supplement designed to quickly and effectively increase Coenzyme Q10 (CoQ-10) levels in the body.* It is formulated with a proprietary oil-based delivery system and natural vitamin E for enhanced absorption and maximum stability.* Thus, it may support your cardiovascular health, antioxidation and energy production.*
Who Can Use CoQ-10 300 MG for?
CoQ-10 300 MG by Ortho Molecular Products may be for you if:
- you want to support cardiovascular and neurological health*
- you struggle with the feeling of fatigue or low energy levels*
- you wish to maintain healthy blood sugar levels*
What May CoQ-10 300 MG by Ortho Molecular Products Support?
Ortho Molecular Products CoQ-10 300MG may offer the following benefits:
- increased CoQ-10 levels in the body for optimal energy production*
- improved cardiovascular and neurological health*
- enhanced antioxidant activity and blood sugar balance*
Supplements support your health but do not replace a balanced diet. Always check with your doctor if you have doubts about a new supplement. If you have any further questions regarding CoQ-10 300 MG by Ortho Molecular Products or any other supplements sold at Covenant Health Products, discuss them with a medical advisor at a FREE consultation.
Recommendation:
Ortho Molecular Products suggests taking 1 CoQ-10 300mg soft gel capsule per day or as recommended by your health care professional.
Serving Size: 1 soft gel capsule
Servings Per Container: 30 or 60
Amount Per Serving:
Vitamin E (from 30 IU as d-Alpha Tocopherol) 20mg
CoEnzyme Q10 300 mg
Other Ingredients: D-Limonene Oil, Gelatin, Glycerin, Purified Water, Mixed Tocopherols, Red Radish Powder, Carob Extract Concentrate, Caramel Liquid and Medium Chain Triglycerides.
Click here to view Product Info Sheet
References:
- Hojerova, J. (2000). Coenzyme Q10: Its importance, properties, and use in nutrition and cosmetics. Česká a Slovenská Farmacie, 49, 199–123. [Slovak].
- Ikematsu, H., Nakamura, K., Harashima, S., Fujii, K., & Fukutomi, N. (2006). Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: A double-blind, randomized, placebo-controlled trial. Regulatory Toxicology and Pharmacology, 44(3), 212–218.
- Hargreaves, I. P., Duncan, A. J., Heales, S. J., & Land, J. M. (2005). The effect of HMG-CoA reductase inhibitors on coenzyme Q10: Possible biochemical/clinical implications. Drug Safety, 28, 659–676.
- Langsjoen, P. H., Vadhanavikit, S., & Folkers, K. (1985). Effective treatment with coenzyme Q10 of patients with chronic myocardial disease. Drugs Exp Clin Res, 11, 577–579.
- Langsjoen, P., Langsjoen, P., Willis, R., & Folkers, K. (1994). Treatment of essential hypertension with coenzyme Q10. Molecular Aspects of Medicine, 15(Suppl), S265–S272.
- Stocker, R., Bowry, V. W., & Frei, B. (1991). Ubiquinol-10 protects human low-density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proceedings of the National Academy of Sciences, 88(5), 1646–1650.
- Gaby, A. R. (1996). The role of coenzyme Q10 in clinical medicine: Part II. Cardiovascular disease, hypertension, diabetes mellitus, and infertility. Alternative Medicine Review, 1(3), 168–175.
- Shigeta, Y., Izumi, K., & Abe, H. (1966). Effect of coenzyme Q7 treatment on blood sugar and ketone bodies of diabetics. Journal of Vitaminology, 12, 293–298.
- Mancuso, M., Orsucci, D., Calsolaro, V., Choub, A., & Siciliano, G. (2009). Coenzyme Q10 and neurological diseases. Pharmaceuticals, 2, 134–149.